Product Identification
| Product | Tesamorelin (HXR-TESAMORELIN) |
|---|
| Full name | Tesamorelin (stabilized GHRH(1-44) analog / GHRH receptor agonist peptide) |
|---|
| CAS No. | 218949-48-5 |
|---|
| Molecular formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
|---|
| Molecular weight | 5135.86 g/mol |
|---|
| Appearance | White lyophilized powder |
|---|
| Lot No. | ____ |
|---|
| Manufacture date | ____ |
|---|
| Re-test date | ____ |
|---|
| Quantity | 10 mg |
|---|
Analytical Results
| Test | Method | Specification | Result |
|---|
| Purity | RP-HPLC | ≥98% (HPLC) | ____ |
| Identity | ESI-MS | Consistent with MW | ____ |
| Appearance | Visual | White powder | ____ |
| Solubility | Visual | Soluble in water / AcOH | ____ |
| Water content | Karl Fischer | ≤ spec | ____ |
| Counterion (acetate / TFA) | HPLC | Report | ____ |
SequenceTyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂ (N-terminal Tyr modified with a trans-3-hexenoyl group)
Storage & Handling
Store at −20°C, desiccated, protect from light. Minimize freeze–thaw cycles. Reconstitute under aseptic laboratory conditions.
Reviewed / Approved by ____________________ (QC)
Date ____________________
RESEARCH USE ONLY
Not for human or veterinary use, food, drug, or therapeutic application.
HXR-TESAMORELIN
This certificate is valid only for the lot identified above.